The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia

Clin Infect Dis. 2016 Aug 15:63 Suppl 2:S46-51. doi: 10.1093/cid/ciw245.

Abstract

The Innovative Medicines Initiative-funded COMBACTE consortium fosters academic-industry partnership in pioneering studies to combat serious bacterial infections. We describe how this partnership is advancing the development of 2 monoclonal antibodies, MEDI4893 and MEDI3902, for the prevention of nosocomial pneumonia.

Keywords: ICU; monoclonal antibody; nosocomial pneumonia; ventilator-associated pneumonia.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Cross Infection / prevention & control*
  • Drug Discovery*
  • Humans
  • Pneumonia, Bacterial / prevention & control*
  • Pneumonia, Ventilator-Associated / prevention & control
  • Public-Private Sector Partnerships*
  • United States

Substances

  • Anti-Bacterial Agents
  • Antibodies, Monoclonal